Amyotrophic Lateral Sclerosis Market
Market Insights on Amyotrophic Lateral Sclerosis sales outlook, demand forecast & up-to-date key trends
Amyotrophic Lateral Sclerosis Market By Treatment, Distribution Channel & Region – Forecast 2023–2033
Amyotrophic Lateral Sclerosis Market Snapshot (2023-2033)
The global Amyotrophic Lateral Sclerosis market is expected to garner a market value of US$ 743.90 Million in 2023 and is expected to accumulate a market value of US$ 1332.22 Million by registering a CAGR of 6% in the forecast period 2023-2033. Growth of the Amyotrophic Lateral Sclerosis market can be attributed to the rising geriatric population, growing awareness about ALS, and increasing incidence rate. The market for Amyotrophic Lateral Sclerosis registered a CAGR of 4% in the historical period 2017-2022.
Supplemental approvals for existing treatment options are likely to bolster the market growth in future years. In addition to that, many renowned companies are aiming to submit their applications for the approval for new drug therapies, which is another crucial factor that is estimated to aid the growth.
|
Report Attribute |
Details |
|
Expected Market Value (2023) |
US$ 743.90 Million |
|
Anticipated Forecast Value (2033) |
US$ 1332.22 Million |
|
Projected Growth Rate (2023-2033) |
6% CAGR |
Let us know your requirement to get
100% FREE customization
2017-2022 Amyotrophic Lateral Sclerosis Market Demand Analysis vs. Forecast 2023-2033
According to market research and competitive intelligence provider Future Market Insights- the market for Amyotrophic Lateral Sclerosis reflected a value of 4% during the historical period, 2017-2022. National lockdown, government controls, and a spike in infection rates across countries all had a major financial impact on client engagement.
Amyotrophic lateral sclerosis, a progressive neurodegenerative disorder, damages nerve cells in the central nervous system responsible for controlling the voluntary muscles. As per studies, around half of the people suffering from ALS may lose the ability to swallow, breathe, speak, walk, and use their hands. Thus, the market for Amyotrophic Lateral Sclerosis is expected to register a CAGR of 6% in the forecast period 2023-2033.
Which are Some Prominent Drivers of Amyotrophic Lateral Sclerosis Market?
Increasing incidence of cancer to push the market growth
The increasing prevalence of amyotrophic lateral sclerosis disease is one of the biggest drivers of the market. According to the National Institute of Neurological Disorders and Stroke (NINDS), following gradual paralysis, patients with ALS often die from respiratory failure within 3-5 years. It also states that between the two types of ALS, the sporadic type is the most common form, accounting for 90- 95% of all cases in the U.S. while the familial type accounts for the rest.
In addition to this, an inclination of population towards a stationary lifestyle and increasing geriatric population has increased the demand for targeted and indicating treatment options, which are driving the global amyotrophic lateral sclerosis market.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystWhat are the Challenges Faced by the Amyotrophic Lateral Sclerosis Market?
Expensive Cost of Treatment to restrict Market Growth
The expensive treatment of Amyotrophic lateral sclerosis, less awareness of amyotrophic lateral sclerosis disease, and insubstantial treatment options are hampering the market growth.
Region-Wise Insights
How is the Market for Amyotrophic Lateral Sclerosis Turning Out in the Asia Pacific Region?
Increased revenue generation propelling growth of Amyotrophic Lateral Sclerosis in Asia Pacific
The Asia Pacific is expected to exhibit the fastest growth rate of all regions over the forecast period, with a CAGR of 5% during the forecast period.
The industry is witnessing an increasing revenue generation in this region, especially in India and China. Major factors propelling the market growth in this region include growing R&D investment in the healthcare sector, plenty of unexplored opportunities, and promising initiatives by the manufacturers as well as the governments.
What are the Factors Boosting the Market for Amyotrophic Lateral Sclerosis in North America?
High Concentration of Key Players shaping landscape for Amyotrophic Lateral Sclerosis in North America
North America is anticipated to acquire a market share of about 20% in the forecast period. This growth is attributable to the availability of recently developed immunosuppressants and the presence of a favorable reimbursement scenario across the U.S.
It is estimated that the high healthcare expenditure along with the huge demand for ALS drugs, and established healthcare infrastructure are the factors driving the market. According to the data published in the Centers for Disease Control and Prevention (CDC) Morbidity and Mortality Weekly Report, in 2015 around 16,583 cases of amyotrophic lateral sclerosis were identified in the U.S.
Besides, the presence of a large number of significant pharmaceutical companies in the U.S. is set to bode well for the North America market. Thus, given the aforementioned factors, the market is expected to grow significantly over the forecast period in North America.
A unified Market Research Subscription Platform, built for today's disparate research needs.
Category-Wise Insights
Based on Treatment, Which Segment is Pushing the Market Growth?
Superior efficiency of Stem cell therapy bolstering the growth
On the basis of treatment, the segment has been divided into medications, stem cell therapies, and others. Stem cell therapy is expected to show the highest CAGR owing to the increasing demand for new approaches and advanced treatment options. In addition to this, several initiatives have been taken by the government authoritative bodies and the Collaborative ALS Drug Discovery Initiative (CADDI) to fast-track the development of novel drugs and treatments.
By Distribution Channels, Which Segment Dominates the Market?
Hospital pharmacies to drive market growth
The distribution channel segment has been divided into hospital pharmacies, retail pharmacies, and others. According to the FMI analysis, Hospital pharmacies account for the largest market share. The requirement for several hospital stays and visits during ALS treatment facilitates the growth of this segment.
Start-Up in the Amyotrophic Lateral Sclerosis Market
Key start-up players in the Amyotrophic Lateral Sclerosis market are-
- Since its founding in Tel Aviv in 2017, neurodegenerative disease startup NeuroSense Therapeutics has been eyeing the U.S. market. Now, the company (Nasdaq: NRSN) is using its local headquarters in Cambridge to anchor its efforts to advance a drug that aims to treat amyotrophic lateral sclerosis (ALS).
- QurAlis has raised seed funding from a syndicate featuring Amgen Ventures. The startup will use the cash to advance treatments for three subtypes of amyotrophic lateral sclerosis (ALS). Amgen joined with MP Healthcare Venture Management and Alexandria Venture Investments to put the latest tranche of funding into QurAlis, which bankrolled its early days using money from friends and family investors. Bringing the new investors on board equips QurAlis to advance programs based on understanding of the genetics and biomarkers associated with different types of ALS.
Market Competition
Key players in the Amyotrophic Lateral Sclerosis market are Mitsubishi Tanabe Pharma Corporation; Otsuka Pharmaceutical Co., Ltd.; BrainStorm Therapeutics; Biogen Inc.; Corestem; AB Science; F.Hoffmann-La Roche AG; Biohaven Pharmaceutical; Sun Pharmaceutical; and Ionis Pharmaceuticals, Inc.
- In June 2021, CRISPR Therapeutics and Capsida Biotherapeutics Inc. entered into a strategic partnership to research, develop, manufacture and commercialize in vivo gene editing therapies using CRISPR technology delivered with engineered AAV vectors for the treatment of familial amyotrophic lateral sclerosis (ALS) and Friedreich’s ataxia. Such partnerships are likely to bolster market growth.
- In June 2022, Canada approved Amylyx Pharmaceuticals Inc.’s new drug ALBRIOZA (also known as AMX0035) for amyotrophic lateral sclerosis.
Report Scope
|
Report Attribute |
Details |
|
Market Value in 2023 |
US$ 743.90 Million |
|
Market Value in 2033 |
US$ 1332.22 Million |
|
Growth Rate |
CAGR of 6% from 2023 to 2033 |
|
Base Year for Estimation |
2022 |
|
Historical Data |
2017-2022 |
|
Forecast Period |
2023-2033 |
|
Quantitative Units |
Revenue in USD Million and CAGR from 2023-2033 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
|
|
Customization |
Available Upon Request |
Key Segments Profiled in the Amyotrophic Lateral Sclerosis Industry Survey
Treatment:
- Medication
- Stem Cell Therapy
- Others
Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Region:
- North America
- Latin America
- Europe
- Asia Pacific
- MEA
Frequently Asked Questions
From 2017-2022, the Amyotrophic Lateral Sclerosis market grew at CAGR of 4%.
The global Amyotrophic Lateral Sclerosis market is expected to grow with a 6% CAGR during 2023-2033.
As of 2033, the Amyotrophic Lateral Sclerosis market is expected to reach US$ 1332.22 Million
According to the FMI analysis, Hospital pharmacies account for the largest market share.
Stem cell therapy is expected to show the highest CAGR owing to the increasing demand for new approaches.
North America is expected to possess 20% market share for Amyotrophic Lateral Sclerosis market.
The Asia Pacific market is predicted to increase significantly throughout the forecast period, with a CAGR of 5% during the forecast period.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2018-2022 and Forecast, 2023-2033
4.1. Historical Market Size Value (US$ Mn) Analysis, 2018-2022
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2023-2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Treatment
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Treatment, 2018-2022
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Treatment, 2023-2033
5.3.1. Medication
5.3.2. Stem Cell Therapy
5.3.3. Others
5.4. Y-o-Y Growth Trend Analysis By Treatment, 2018-2022
5.5. Absolute $ Opportunity Analysis By Treatment, 2023-2033
6. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Distribution Channel
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Mn) Analysis By Distribution Channel, 2018-2022
6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033
6.3.1. Hospital Pharmacies
6.3.2. Retail Pharmacies
6.3.3. Others
6.4. Y-o-Y Growth Trend Analysis By Distribution Channel, 2018-2022
6.5. Absolute $ Opportunity Analysis By Distribution Channel, 2023-2033
7. Global Market Analysis 2018-2022 and Forecast 2023-2033, By Region
7.1. Introduction
7.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2018-2022
7.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2023-2033
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. MEA
7.4. Market Attractiveness Analysis By Region
8. North America Market Analysis 2018-2022 and Forecast 2023-2033, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
8.2.1. By Country
8.2.1.1. U.S.
8.2.1.2. Canada
8.2.2. By Treatment
8.2.3. By Distribution Channel
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Treatment
8.3.3. By Distribution Channel
8.4. Key Takeaways
9. Latin America Market Analysis 2018-2022 and Forecast 2023-2033, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
9.2.1. By Country
9.2.1.1. Brazil
9.2.1.2. Mexico
9.2.1.3. Rest of Latin America
9.2.2. By Treatment
9.2.3. By Distribution Channel
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Treatment
9.3.3. By Distribution Channel
9.4. Key Takeaways
10. Europe Market Analysis 2018-2022 and Forecast 2023-2033, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
10.2.1. By Country
10.2.1.1. Germany
10.2.1.2. U.K.
10.2.1.3. France
10.2.1.4. Spain
10.2.1.5. Italy
10.2.1.6. Rest of Europe
10.2.2. By Treatment
10.2.3. By Distribution Channel
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Treatment
10.3.3. By Distribution Channel
10.4. Key Takeaways
11. Asia Pacific Market Analysis 2018-2022 and Forecast 2023-2033, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
11.2.1. By Country
11.2.1.1. China
11.2.1.2. Japan
11.2.1.3. South Korea
11.2.1.4. Singapore
11.2.1.5. Thailand
11.2.1.6. Indonesia
11.2.1.7. Australia
11.2.1.8. New Zealand
11.2.1.9. Rest of Asia Pacific
11.2.2. By Treatment
11.2.3. By Distribution Channel
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Treatment
11.3.3. By Distribution Channel
11.4. Key Takeaways
12. MEA Market Analysis 2018-2022 and Forecast 2023-2033, By Country
12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2023-2033
12.2.1. By Country
12.2.1.1. GCC Countries
12.2.1.2. South Africa
12.2.1.3. Israel
12.2.1.4. Rest of MEA
12.2.2. By Treatment
12.2.3. By Distribution Channel
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Treatment
12.3.3. By Distribution Channel
12.4. Key Takeaways
13. Key Countries Market Analysis
13.1. U.S.
13.1.1. Pricing Analysis
13.1.2. Market Share Analysis, 2022
13.1.2.1. By Treatment
13.1.2.2. By Distribution Channel
13.2. Canada
13.2.1. Pricing Analysis
13.2.2. Market Share Analysis, 2022
13.2.2.1. By Treatment
13.2.2.2. By Distribution Channel
13.3. Brazil
13.3.1. Pricing Analysis
13.3.2. Market Share Analysis, 2022
13.3.2.1. By Treatment
13.3.2.2. By Distribution Channel
13.4. Mexico
13.4.1. Pricing Analysis
13.4.2. Market Share Analysis, 2022
13.4.2.1. By Treatment
13.4.2.2. By Distribution Channel
13.5. Germany
13.5.1. Pricing Analysis
13.5.2. Market Share Analysis, 2022
13.5.2.1. By Treatment
13.5.2.2. By Distribution Channel
13.6. U.K.
13.6.1. Pricing Analysis
13.6.2. Market Share Analysis, 2022
13.6.2.1. By Treatment
13.6.2.2. By Distribution Channel
13.7. France
13.7.1. Pricing Analysis
13.7.2. Market Share Analysis, 2022
13.7.2.1. By Treatment
13.7.2.2. By Distribution Channel
13.8. Spain
13.8.1. Pricing Analysis
13.8.2. Market Share Analysis, 2022
13.8.2.1. By Treatment
13.8.2.2. By Distribution Channel
13.9. Italy
13.9.1. Pricing Analysis
13.9.2. Market Share Analysis, 2022
13.9.2.1. By Treatment
13.9.2.2. By Distribution Channel
13.10. China
13.10.1. Pricing Analysis
13.10.2. Market Share Analysis, 2022
13.10.2.1. By Treatment
13.10.2.2. By Distribution Channel
13.11. Japan
13.11.1. Pricing Analysis
13.11.2. Market Share Analysis, 2022
13.11.2.1. By Treatment
13.11.2.2. By Distribution Channel
13.12. South Korea
13.12.1. Pricing Analysis
13.12.2. Market Share Analysis, 2022
13.12.2.1. By Treatment
13.12.2.2. By Distribution Channel
13.13. Singapore
13.13.1. Pricing Analysis
13.13.2. Market Share Analysis, 2022
13.13.2.1. By Treatment
13.13.2.2. By Distribution Channel
13.14. Thailand
13.14.1. Pricing Analysis
13.14.2. Market Share Analysis, 2022
13.14.2.1. By Treatment
13.14.2.2. By Distribution Channel
13.15. Indonesia
13.15.1. Pricing Analysis
13.15.2. Market Share Analysis, 2022
13.15.2.1. By Treatment
13.15.2.2. By Distribution Channel
13.16. Australia
13.16.1. Pricing Analysis
13.16.2. Market Share Analysis, 2022
13.16.2.1. By Treatment
13.16.2.2. By Distribution Channel
13.17. New Zealand
13.17.1. Pricing Analysis
13.17.2. Market Share Analysis, 2022
13.17.2.1. By Treatment
13.17.2.2. By Distribution Channel
13.18. GCC Countries
13.18.1. Pricing Analysis
13.18.2. Market Share Analysis, 2022
13.18.2.1. By Treatment
13.18.2.2. By Distribution Channel
13.19. South Africa
13.19.1. Pricing Analysis
13.19.2. Market Share Analysis, 2022
13.19.2.1. By Treatment
13.19.2.2. By Distribution Channel
13.20. Israel
13.20.1. Pricing Analysis
13.20.2. Market Share Analysis, 2022
13.20.2.1. By Treatment
13.20.2.2. By Distribution Channel
14. Market Structure Analysis
14.1. Competition Dashboard
14.2. Competition Benchmarking
14.3. Market Share Analysis of Top Players
14.3.1. By Regional
14.3.2. By Treatment
14.3.3. By Distribution Channel
15. Competition Analysis
15.1. Competition Deep Dive
15.1.1. Mitsubishi Tanabe Pharma Corporation
15.1.1.1. Overview
15.1.1.2. Product Portfolio
15.1.1.3. Profitability by Market Segments
15.1.1.4. Sales Footprint
15.1.1.5. Strategy Overview
15.1.1.5.1. Marketing Strategy
15.1.2. Otsuka Pharmaceutical Co., Ltd.
15.1.2.1. Overview
15.1.2.2. Product Portfolio
15.1.2.3. Profitability by Market Segments
15.1.2.4. Sales Footprint
15.1.2.5. Strategy Overview
15.1.2.5.1. Marketing Strategy
15.1.3. BrainStorm Therapeutics
15.1.3.1. Overview
15.1.3.2. Product Portfolio
15.1.3.3. Profitability by Market Segments
15.1.3.4. Sales Footprint
15.1.3.5. Strategy Overview
15.1.3.5.1. Marketing Strategy
15.1.4. Biogen Inc.
15.1.4.1. Overview
15.1.4.2. Product Portfolio
15.1.4.3. Profitability by Market Segments
15.1.4.4. Sales Footprint
15.1.4.5. Strategy Overview
15.1.4.5.1. Marketing Strategy
15.1.5. Corestem
15.1.5.1. Overview
15.1.5.2. Product Portfolio
15.1.5.3. Profitability by Market Segments
15.1.5.4. Sales Footprint
15.1.5.5. Strategy Overview
15.1.5.5.1. Marketing Strategy
15.1.6. AB Science
15.1.6.1. Overview
15.1.6.2. Product Portfolio
15.1.6.3. Profitability by Market Segments
15.1.6.4. Sales Footprint
15.1.6.5. Strategy Overview
15.1.6.5.1. Marketing Strategy
15.1.7. F.Hoffmann-La Roche AG
15.1.7.1. Overview
15.1.7.2. Product Portfolio
15.1.7.3. Profitability by Market Segments
15.1.7.4. Sales Footprint
15.1.7.5. Strategy Overview
15.1.7.5.1. Marketing Strategy
15.1.8. Biohaven Pharmaceutical
15.1.8.1. Overview
15.1.8.2. Product Portfolio
15.1.8.3. Profitability by Market Segments
15.1.8.4. Sales Footprint
15.1.8.5. Strategy Overview
15.1.8.5.1. Marketing Strategy
15.1.9. Sun Pharmaceutical
15.1.9.1. Overview
15.1.9.2. Product Portfolio
15.1.9.3. Profitability by Market Segments
15.1.9.4. Sales Footprint
15.1.9.5. Strategy Overview
15.1.9.5.1. Marketing Strategy
15.1.10. Ionis Pharmaceuticals, Inc.
15.1.10.1. Overview
15.1.10.2. Product Portfolio
15.1.10.3. Profitability by Market Segments
15.1.10.4. Sales Footprint
15.1.10.5. Strategy Overview
15.1.10.5.1. Marketing Strategy
16. Assumptions & Acronyms Used
17. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: Global Market Value (US$ Mn) Forecast by Region, 2018-2033
Table 2: Global Market Value (US$ Mn) Forecast by Treatment, 2018-2033
Table 3: Global Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033
Table 4: North America Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 5: North America Market Value (US$ Mn) Forecast by Treatment, 2018-2033
Table 6: North America Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033
Table 7: Latin America Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 8: Latin America Market Value (US$ Mn) Forecast by Treatment, 2018-2033
Table 9: Latin America Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033
Table 10: Europe Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 11: Europe Market Value (US$ Mn) Forecast by Treatment, 2018-2033
Table 12: Europe Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033
Table 13: Asia Pacific Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 14: Asia Pacific Market Value (US$ Mn) Forecast by Treatment, 2018-2033
Table 15: Asia Pacific Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033
Table 16: MEA Market Value (US$ Mn) Forecast by Country, 2018-2033
Table 17: MEA Market Value (US$ Mn) Forecast by Treatment, 2018-2033
Table 18: MEA Market Value (US$ Mn) Forecast by Distribution Channel, 2018-2033
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: Global Market Value (US$ Mn) by Treatment, 2023-2033
Figure 2: Global Market Value (US$ Mn) by Distribution Channel, 2023-2033
Figure 3: Global Market Value (US$ Mn) by Region, 2023-2033
Figure 4: Global Market Value (US$ Mn) Analysis by Region, 2018-2033
Figure 5: Global Market Value Share (%) and BPS Analysis by Region, 2023-2033
Figure 6: Global Market Y-o-Y Growth (%) Projections by Region, 2023-2033
Figure 7: Global Market Value (US$ Mn) Analysis by Treatment, 2018-2033
Figure 8: Global Market Value Share (%) and BPS Analysis by Treatment, 2023-2033
Figure 9: Global Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033
Figure 10: Global Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033
Figure 11: Global Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 12: Global Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 13: Global Market Attractiveness by Treatment, 2023-2033
Figure 14: Global Market Attractiveness by Distribution Channel, 2023-2033
Figure 15: Global Market Attractiveness by Region, 2023-2033
Figure 16: North America Market Value (US$ Mn) by Treatment, 2023-2033
Figure 17: North America Market Value (US$ Mn) by Distribution Channel, 2023-2033
Figure 18: North America Market Value (US$ Mn) by Country, 2023-2033
Figure 19: North America Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 20: North America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 21: North America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 22: North America Market Value (US$ Mn) Analysis by Treatment, 2018-2033
Figure 23: North America Market Value Share (%) and BPS Analysis by Treatment, 2023-2033
Figure 24: North America Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033
Figure 25: North America Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033
Figure 26: North America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 27: North America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 28: North America Market Attractiveness by Treatment, 2023-2033
Figure 29: North America Market Attractiveness by Distribution Channel, 2023-2033
Figure 30: North America Market Attractiveness by Country, 2023-2033
Figure 31: Latin America Market Value (US$ Mn) by Treatment, 2023-2033
Figure 32: Latin America Market Value (US$ Mn) by Distribution Channel, 2023-2033
Figure 33: Latin America Market Value (US$ Mn) by Country, 2023-2033
Figure 34: Latin America Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 35: Latin America Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 36: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 37: Latin America Market Value (US$ Mn) Analysis by Treatment, 2018-2033
Figure 38: Latin America Market Value Share (%) and BPS Analysis by Treatment, 2023-2033
Figure 39: Latin America Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033
Figure 40: Latin America Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033
Figure 41: Latin America Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 42: Latin America Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 43: Latin America Market Attractiveness by Treatment, 2023-2033
Figure 44: Latin America Market Attractiveness by Distribution Channel, 2023-2033
Figure 45: Latin America Market Attractiveness by Country, 2023-2033
Figure 46: Europe Market Value (US$ Mn) by Treatment, 2023-2033
Figure 47: Europe Market Value (US$ Mn) by Distribution Channel, 2023-2033
Figure 48: Europe Market Value (US$ Mn) by Country, 2023-2033
Figure 49: Europe Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 50: Europe Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 51: Europe Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 52: Europe Market Value (US$ Mn) Analysis by Treatment, 2018-2033
Figure 53: Europe Market Value Share (%) and BPS Analysis by Treatment, 2023-2033
Figure 54: Europe Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033
Figure 55: Europe Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033
Figure 56: Europe Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 57: Europe Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 58: Europe Market Attractiveness by Treatment, 2023-2033
Figure 59: Europe Market Attractiveness by Distribution Channel, 2023-2033
Figure 60: Europe Market Attractiveness by Country, 2023-2033
Figure 61: Asia Pacific Market Value (US$ Mn) by Treatment, 2023-2033
Figure 62: Asia Pacific Market Value (US$ Mn) by Distribution Channel, 2023-2033
Figure 63: Asia Pacific Market Value (US$ Mn) by Country, 2023-2033
Figure 64: Asia Pacific Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 65: Asia Pacific Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 66: Asia Pacific Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 67: Asia Pacific Market Value (US$ Mn) Analysis by Treatment, 2018-2033
Figure 68: Asia Pacific Market Value Share (%) and BPS Analysis by Treatment, 2023-2033
Figure 69: Asia Pacific Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033
Figure 70: Asia Pacific Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033
Figure 71: Asia Pacific Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 72: Asia Pacific Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 73: Asia Pacific Market Attractiveness by Treatment, 2023-2033
Figure 74: Asia Pacific Market Attractiveness by Distribution Channel, 2023-2033
Figure 75: Asia Pacific Market Attractiveness by Country, 2023-2033
Figure 76: MEA Market Value (US$ Mn) by Treatment, 2023-2033
Figure 77: MEA Market Value (US$ Mn) by Distribution Channel, 2023-2033
Figure 78: MEA Market Value (US$ Mn) by Country, 2023-2033
Figure 79: MEA Market Value (US$ Mn) Analysis by Country, 2018-2033
Figure 80: MEA Market Value Share (%) and BPS Analysis by Country, 2023-2033
Figure 81: MEA Market Y-o-Y Growth (%) Projections by Country, 2023-2033
Figure 82: MEA Market Value (US$ Mn) Analysis by Treatment, 2018-2033
Figure 83: MEA Market Value Share (%) and BPS Analysis by Treatment, 2023-2033
Figure 84: MEA Market Y-o-Y Growth (%) Projections by Treatment, 2023-2033
Figure 85: MEA Market Value (US$ Mn) Analysis by Distribution Channel, 2018-2033
Figure 86: MEA Market Value Share (%) and BPS Analysis by Distribution Channel, 2023-2033
Figure 87: MEA Market Y-o-Y Growth (%) Projections by Distribution Channel, 2023-2033
Figure 88: MEA Market Attractiveness by Treatment, 2023-2033
Figure 89: MEA Market Attractiveness by Distribution Channel, 2023-2033
Figure 90: MEA Market Attractiveness by Country, 2023-2033
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
